Lenox Wealth Management’s AstraZeneca AZN Stock Holding History

Lenox Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$38K	Hold	361	–	–	0.01%	288
2020 Q1	$32K	Buy	361 +16	+5%	+$1.51K	0.01%	282
2019 Q4	$34K	Buy	345 +2	+0.6%	+$188	0.01%	303
2019 Q3	$30K	Buy	343 +3	+0.9%	+$260	0.01%	311
2019 Q2	$28K	Sell	340 -14	-4%	-$1.1K	0.01%	300
2019 Q1	$29K	Sell	354 -76	-18%	-$5.99K	0.01%	293
2018 Q4	$33K	Buy	430 +91	+27%	+$7.11K	0.01%	242
2018 Q3	$27K	Buy	339 +72	+27%	+$5.45K	0.01%	281
2018 Q2	$19K	Buy	267 +33	+14%	+$2.37K	0.01%	297
2018 Q1	$16K	Buy	234 +209	+836%	+$14.5K	0.01%	316
2017 Q4	$2K	Buy	+25	New	+$1.69K	﹤0.01%	454

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Lenox Wealth Management's AZN Position: Q2 2020 in Review

Lenox Wealth Management held its AstraZeneca (AZN) position steady in Q2 2020 at 361 shares worth $38K. The position accounts for 0.01% of the portfolio, ranked #288.

Lenox Wealth Management first reported a position in AZN in Q4 2017 and has held it in 11 quarters since. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

Lenox Wealth Management held 361 shares of AstraZeneca worth $38K as of Q2 2020.
Lenox Wealth Management left its AstraZeneca share count unchanged in Q2 2020.
AstraZeneca made up 0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #288 holding.
Lenox Wealth Management first reported a position in AstraZeneca in Q4 2017 and has held it in 11 quarters since.
669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.